1. Home
  2. NMRA vs MBVI Comparison

NMRA vs MBVI Comparison

Compare NMRA & MBVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • MBVI
  • Stock Information
  • Founded
  • NMRA 2019
  • MBVI 2025
  • Country
  • NMRA United States
  • MBVI United States
  • Employees
  • NMRA N/A
  • MBVI N/A
  • Industry
  • NMRA
  • MBVI
  • Sector
  • NMRA
  • MBVI
  • Exchange
  • NMRA Nasdaq
  • MBVI Nasdaq
  • Market Cap
  • NMRA 424.4M
  • MBVI 435.6M
  • IPO Year
  • NMRA 2023
  • MBVI 2025
  • Fundamental
  • Price
  • NMRA $2.20
  • MBVI $10.03
  • Analyst Decision
  • NMRA Buy
  • MBVI
  • Analyst Count
  • NMRA 8
  • MBVI 0
  • Target Price
  • NMRA $7.57
  • MBVI N/A
  • AVG Volume (30 Days)
  • NMRA 1.9M
  • MBVI 52.8K
  • Earning Date
  • NMRA 11-06-2025
  • MBVI 01-01-0001
  • Dividend Yield
  • NMRA N/A
  • MBVI N/A
  • EPS Growth
  • NMRA N/A
  • MBVI N/A
  • EPS
  • NMRA N/A
  • MBVI N/A
  • Revenue
  • NMRA N/A
  • MBVI N/A
  • Revenue This Year
  • NMRA N/A
  • MBVI N/A
  • Revenue Next Year
  • NMRA N/A
  • MBVI N/A
  • P/E Ratio
  • NMRA N/A
  • MBVI N/A
  • Revenue Growth
  • NMRA N/A
  • MBVI N/A
  • 52 Week Low
  • NMRA $0.61
  • MBVI $10.00
  • 52 Week High
  • NMRA $11.57
  • MBVI $10.50
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 41.50
  • MBVI N/A
  • Support Level
  • NMRA $2.55
  • MBVI N/A
  • Resistance Level
  • NMRA $2.78
  • MBVI N/A
  • Average True Range (ATR)
  • NMRA 0.26
  • MBVI 0.00
  • MACD
  • NMRA -0.09
  • MBVI 0.00
  • Stochastic Oscillator
  • NMRA 10.56
  • MBVI 0.00

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About MBVI M3-Brigade Acquisition VI Corp. Class A Ordinary Shares

M3-Brigade Acquisition VI Corp is a newly incorporated blank check company.

Share on Social Networks: